XML 57 R40.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation (Tables)
 3 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Incentive Equity Awards
The activity related to the Company’s incentive equity awards for the three months ended September 30, 2024 consisted of the following:
Stock OptionsTime-based
Restricted Stock Units		Performance-based
Restricted Stock Units
Number of
Options		Weighted-
Average
Exercise
Price		Number
of Shares		Weighted-
Average
Grant
Date Fair
Value		Number
of Shares		Weighted-
Average
Grant
Date Fair
Value
Balances at June 30, 2024
2,180,621 $132.68 682,684 $146.05 161,805 $152.21 
Granted— — 10,433 211.67 — — 
Exercise of stock options (a)(180,774)99.29 — — — — 
Vesting of restricted stock units
— — (4,689)158.51 — — 
Expired/forfeited(200)198.30 (8,774)161.51 (3,096)143.81 
Balances at September 30, 2024 (b),(c)
1,999,647 $135.69 679,654 $146.77 158,709 $152.37 
_________
(a)Stock options exercised during the period of July 1, 2024 through September 30, 2024 had an aggregate intrinsic value of $20.0 million.
(b)As of September 30, 2024, the Company’s outstanding vested and currently exercisable stock options using the September 30, 2024 closing stock price of $215.03 (approximately 1.2 million shares) had an aggregate intrinsic value of $115.8 million with a weighted-average exercise price of $116.37 and a weighted-average remaining contractual life of 4.9 years. The total of all stock options outstanding as of September 30, 2024 has a weighted-average remaining contractual life of 6.3 years.
(c)As of September 30, 2024, time-based restricted stock units and performance-based restricted stock units expected to vest using the September 30, 2024 closing stock price of $215.03 (approximately 0.6 million and 0.2 million shares, respectively) had an aggregate intrinsic value of $139.5 million and $32.3 million, respectively. Performance-based restricted stock units granted in the table above represent initial target awards, and performance adjustments for (i) change in shares issued based upon attainment of performance goals determined in the period, and (ii) estimated change in shares issued resulting from attainment of performance goals to be determined at the end of the prospective performance period.